Myriad Genetics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.71

+0.10 (+2.17%)

As of Mar 25, 2:51 PM ET ·

Analyst Consensus

Sell

Analysts

High

Coverage

Buy 3 17%

Hold 9 50%

Sell 6 33%

Price Target

Analyst Price Target +779.8% upside

Low Target $29.39

Average Target $41.44

High Target $63.29

Current Price $4.71

Current
$4.71

Target
$41.44

$29.39 $41.44 avg $63.29

Scenario Analysis

Bear Case

$29.39

524.0%

Low target

Base Case

$41.44

+779.8%

Avg target

Bull Case

$63.29

+1,243.7%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$15.47

-69.6% from high

52-Week Low

$3.76

+25.3% from low

Target vs 52W High

$41.44

+167.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%